1
Clinical Trials associated with Fecal microbiota transplantation(Assistance Publique des Hôpitaux de Paris) / Not yet recruitingPhase 2IIT Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation
Primary Sclerosing Cholangitis (PSC) is a rare cholestatic liver disease, commonly associated with inflammatory bowel disease (IBD) The aim of the present trial is to assess the efficacy of fecal microbiota transplantation (FMT) on ALP and bilirubin compared to sham transplantation in addition to ursodeoxycholic acid (UDCA) treatment in PSC patients.
100 Clinical Results associated with Fecal microbiota transplantation(Assistance Publique des Hôpitaux de Paris)
100 Translational Medicine associated with Fecal microbiota transplantation(Assistance Publique des Hôpitaux de Paris)
100 Patents (Medical) associated with Fecal microbiota transplantation(Assistance Publique des Hôpitaux de Paris)
100 Deals associated with Fecal microbiota transplantation(Assistance Publique des Hôpitaux de Paris)